Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Century Communities | CCS | Jan 17, 2025 | 76.05 | -1.71 |
Century Therapeutics | IPSC | Jan 17, 2025 | 0.91 | +0.45 |
Cepton | CPTN | Jan 17, 2025 | 3.25 | 0.00 |
Ceragon Networks | CRNT | Jan 17, 2025 | 4.49 | -1.54 |
Cerence | CRNC | Jan 17, 2025 | 12.58 | -2.25 |
CeriBell | CBLL | Jan 17, 2025 | 21.04 | 0.00 |
CERo Therapeutics | CERO | Jan 17, 2025 | 2.34 | -6.02 |
Certara | CERT | Jan 17, 2025 | 11.66 | -0.85 |
Cerus | CERS | Jan 17, 2025 | 1.79 | -1.65 |
CervoMed | CRVO | Jan 17, 2025 | 2.11 | 0.00 |
CEVA | CEVA | Jan 17, 2025 | 34.18 | +2.55 |
CF Acquisition VII A | CFFS | Jan 17, 2025 | 11.28 | 0.00 |
CF Bankshares | CFBK | Jan 17, 2025 | 22.85 | +2.42 |
CF Industries | CF | Jan 17, 2025 | 97.01 | -0.25 |
CFSB Bancorp | CFSB | Jan 17, 2025 | 6.94 | +1.02 |
CG Oncology | CGON | Jan 17, 2025 | 29.08 | -0.07 |
CGI | GIB | Jan 17, 2025 | 108.49 | -0.24 |
Chain Bridge Bancorp | CBNA | Jan 17, 2025 | 24.35 | +0.37 |
Champion Homes | SKY | Jan 17, 2025 | 90.61 | -1.72 |
Champions Oncology | CSBR | Jan 17, 2025 | 9.78 | -1.71 |
ChampionX | CHX | Jan 17, 2025 | 31.21 | +7.07 |
Channel Therapeutics | CHRO | Jan 17, 2025 | 1.90 | +97.92 |
Chanson International | CHSN | Jan 17, 2025 | 5.85 | +2.27 |
ChargePoint | CHPT | Jan 17, 2025 | 1.08 | -1.82 |
Charles & Colvard | CTHR | Jan 17, 2025 | 1.52 | +1.00 |
Charles River Laboratories International | CRL | Jan 17, 2025 | 163.50 | -1.39 |
Charles Schwab | SCHW | Jan 17, 2025 | 76.41 | +1.19 |
Charlton Aria Acquisition | CHAR | Jan 17, 2025 | 10.01 | 0.00 |
Charlton Aria Acquisition Unit | CHARU | Jan 17, 2025 | 10.20 | 0.00 |
Chart Industries | GTLS | Jan 17, 2025 | 214.24 | -0.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.